medications contraindicated with semaglutide Compounded is not the same as FDA-approved. The FDA has documented dosing errors and hospitalizations linked to these products. Dr. Jen Ashton breaks down the risks. Always consult your physician before FDA Approves Oral Semaglutide for
Description
Semaglutide is a insulin-like peptide-1 receptor agonist (GLP-1 RA) developed by the Danish pharmaceutical company Novo Nordisk for the treatment of type 2 diabetes

During her hospital stay she admitted to having used semaglutide

Electrolyte imbalancesparticularly involving sodium, potassium, and magnesiumrepresent serious risks during prolonged fasting, potentially leading to cardiac arrhythmias, muscle weakness, and confusion

aim for 1,2001,500 calories daily even if appetite is suppressed

Meltwater Explore+ analysis found tirzepatide-related subreddits accounted for roughly 44% of mentions across the top 30 GLP-1 communities, significantly outpacing semaglutide-focused discussion
